Goldman Sachs Group (GS)

April employment report: strong job growth, slow wage growth = stable inflation, potential rate cuts. Financial ETFs may benefit from this balance.

Lyft stock rises on $1.45B revenue, $750M buyback plan. Needham reiterates hold, Goldman Sachs upgrades to buy with PT of $20. Strong growth despite competition.

Engine Capital said it is ending its campaign to give Lyft time to deliver on its new commitments following recent board discussions.

After 60 years at the helm of Berkshire Hathaway, the Oracle of Omaha is ready for retirement.

Cloudflare stock fell on Q1 earnings that met views while revenue  topped estimates and revenue guidance met expectations.

Bumble shares surged 20% Thursday after reporting mixed Q1 results. CEO Whitney Wolfe Herd emphasized growth focus, leadership changes and Goldman Sachs raised its price target.

While the economic slowdown may take time to show up in hard data, Goldman Sachs still projects three rate cuts later this year.

The drugmaker’s first-quarter revenue of $41.1 million came in well below the consensus estimate of $56.7 million, attributed to changes in AbbVie’s gross-to-net rebate reserves.

Goldman Sachs analyst maintains Neutral rating on Tesla with price target of $235, citing importance of leveraging FSD in China's large vehicle market.

Ford's first-quarter 2025 earnings exceeded forecasts, with an adjusted EPS of $0.14, outperforming estimates. Despite tariff challenges, Ford maintains a strong position in the U.S. truck market. Analysts note a solid outlook, though the company has suspended its 2025 guidance amid supply chain and policy uncertainties. Goldman Sachs raised the price target, while BofA reiterated a Buy rating.

Marjorie Taylor Greene disclosed buying more than 50 stocks in early May. A look at the list and why the congresswoman's past trades have drawn red flags.

Expectations are low for the media bellwether heading into an important financial update on Wednesday.

Wells Fargo just approved a $40 billion buyback program for its own stock, giving investors some signs of potential rebounds and rallies in the future.

There are plenty of good ones to choose from, but these three are all undervalued, leaving them ripe for a lot of bullishness sooner than later.

Shares of healthcare services company Sotera Health (NASDAQ:) jumped 5.9% in the pre-market session after Goldman Sachs analyst Matthew Sykes upgraded the stock from Neutral to Buy and raised the price target from $14 to $17. Sykes emphasized that SHC's consistent exposure to the commercial pharmaceutical and medical device sectors, both of which are considered essential and relatively insulated from economic cycles, positions the company as a more compelling investment amid growing macroeconomic uncertainty.

Goldman Sachs upgrades Sotera Health to Buy, citing tariff immunity, legal clarity, and exposure to Medtech innovation for future growth.

OPEC+ hike in production and Goldman's oil price forecast decrease led to a selloff in US energy stocks. Brent and WTI may drop to $40s by 2026.

Amazon beat Q1 expectations and analysts are very much bullish, with some price targets calling for almost 50% upside from current levels.

Apprehensions regarding deal closure, Trump’s tariff threat, earnings anxiety and a delayed product launch led to a spike in activity levels for these stocks.

Eli Lilly's Zepbound loses CVS coverage to Wegovy, prompting analyst debate on pricing pressures and long-term obesity market potential.